A Review of Trikafta: Triple Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator Therapy
2021 · Cureus · 100 citations
https://doi.org/10.7759/cureus.16144
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
24
Papers
214
Citations
7
h-index
5
i10-index
Dalal Elsori is an academic researcher from Rhode Island Hospital. The author has contributed to research in topics: Attention Deficit Hyperactivity Disorder & Bipolar Disorder and Treatment & Autism Spectrum Disorder Research. The author has an h-index of 7, co-authored 21 publications.
Click to start Chat